Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype

Leukemia

Volumn 17, Issue 4, 2003, Pages 751-759

  Moisan, S ^a   Demers, M ^a   Mercier, J ^a   Magnaldo, T ^b   Potworowski, E F ^a   St Pierre, Y ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b CNRS   (France)

Author keywords

cDNA array; DNA methylation; Galectin 7; Lymphoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; GALECTIN; GALECTIN 7; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CELL SELECTION; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFICACY; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; IN VIVO STUDY; KIDNEY; LYMPHOMA; LYMPHOMA CELL; MALE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; THYMUS; UPREGULATION;

EID: 0037398950     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402870     Document Type: Article

References (52)

1. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980; 283: 139-146.
2. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000; 405: 827-836.
3. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
4. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 1991; 9: 27-66.
5. Stroeken PJ, van Rijthoven EA, van der Valk MA, Roos E. Targeted disruption of the beta1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity. Cancer Res 1998; 58: 1569-1577.
6. Aoudjit F, Potworowski EF, Springer TA, St-Pierre Y. Protection from lymphoma cell metastasis in ICAM-1 mutant mice: a posthoming event. J Immunol 1998; 161: 2333-2338.
7. Sligh JE, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1993; 90: 8529-8533.
8. Xu H, Gonzalo JA, St Pierre Y, Williams IR, Kupper TS, Cotran RS et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med 1994; 180: 95-109.
9. Dolcetti R, Maestro R, Gasparotto D, Rizzo S, Boiocchi M. Adhesion molecule expression does not influence the leukemic behavior of murine T-cell lymphomas. Leukemia 1992; 6(Suppl 3): 101S-105S.
10. Aoudjit F, Potworowski EF, St-Pierre Y. The metastatic characteristics of murine lymphoma cell lines in vivo are manifested after target organ invasion. Blood 1998; 91: 623-629.
11. Jonas P, Holzmann B, Jablonski-Westrich D, Hamann A. Dissemination capacity of murine lymphoma cells is not dependent on efficient homing. Int J Cancer 1998; 77: 402-407.
12. Aoudjit F, Potworowski EF, St-Pierre Y. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. J Immunol 1998; 160: 2967-2973.
13. Bogetto L, Gabriele E, Cariati R, Dolcetti R, Spessotto P, Doglioni C et al. Bidirectional induction of the cognate receptor-ligand alpha4/VCAM-1 pair defines a novel mechanism of tumor intravasation. Blood 2000; 95: 2397-2406.
14. Lalancette M, Aoudjit F, Potworowski EF, St-Pierre Y. Resistance of ICAM-1-deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells. Blood 2000; 95: 314-319.
15. Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 1997; 89: 1708-1715.
16. Kossakowska AE, Hinek A, Edwards DR, Lim MS, Zhang CL, Breitman DR et al. Proteolytic activity of human non-Hodgkin's lymphomas. Am J Pathol 1998; 152: 565-576.
17. Imamura J, Miyoshi I, Koeffler HP. p53 in hematologic malignancies. Blood 1994; 84: 2412-2421.
18. Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez PL et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 91: 2977-2984.
19. Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado MA et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996; 87: 3351-3359.
20. Madsen P, Rasmussen HH, Flint T, Gromov P, Kruse TA, Honore B et al. Cloning, expression, and chromosome mapping of human galectin-7. J Biol Chem 1995; 270: 5823-5829.
21. Magnaldo T, Bernerd F, Darmon M. Galectin-7, a human 14-kDa S-lectin, specifically expressed in keratinocytes and sensitive to retinoic acid. Dev Biol 1995; 168: 259-271.
22. Lu J, Pei H, Kaeck M, Thompson HJ. Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog 1997; 20: 204-215.
23. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-305.
24. Bernerd F, Sarasin A, Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci USA 1999; 96: 11329-11334.
25. Magnaldo T, Fowlis D, Darmon M. Galectin-7, a marker of all types of stratified epithelia. Differentiation 1998; 63: 159-168.
26. Masters JR, Lakhani SR. How diagnosis with microarrays can help cancer patients. Nature 2000; 404: 921.
27. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537.
28. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511.
29. Wellmann A, Thieblemont C, Pittaluga S, Sakai A, Jaffe ES, Siebert P et al. Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. Blood 2000; 96: 398-404.
30. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000; 406: 532-535.
31. Lossos IS, Alizadeh AA, Eisen MB, Chan WC, Brown PO, Botstein D et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci USA 2000; 97: 10209-10213.
32. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89-92.
33. Laird PW, Jaenisch R. The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 1996; 30: 441-464.
34. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16: 168-174.
35. Pogribny IP, Pogribna M, Christman JK, James SJ. Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: possible in vivo relevance during tumorigenesis. Cancer Res 2000; 60: 588-594.
36. Kudo S, Fukuda M. Tissue-specific transcriptional regulation of human leukosialin (CD43) gene is achieved by DNA methylation. J Biol Chem 1995; 270:13298-13302.
37. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89-92.
38. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 2001; 27: 31-39.
39. Chen D, Rudland PS, Chen HL, Barraclough R. Differential reactivity of the rat S100A4(p9Ka) gene to sodium bisulfite is associated with differential levels of the S100A4 (p9Ka) mRNA in rat mammary epithelial cells. J Biol Chem 1999; 274: 2483-2491.
40. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820-1828.
41. MacDougall JR, Bani MR, Lin Y, Muschel RJ, Kerbel RS. 'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression. Br J Cancer 1999; 80: 504-512.
42. Trainer DL, Kline T, Mallon F, Greig R, Poste G. Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells. Cancer Res 1985; 45: 6124-6130.
43. Aoudjit F, Masure S, Opdenakker G, Potworowski EF, St-Pierre Y. Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma. Int J Cancer 1999; 82: 743-747.
44. St-Pierre Y, Aoudjit F, Lalancette M, Potworowski EF. Dissemination of T cell lymphoma to target organs: a post-homing event implicating ICAM-1 and matrix metalloproteinases. Leukemia Lymphoma 1999; 34: 53-61.
45. Haier J, Nicolson GL. Tumor cell adhesion under hydrodynamic conditions of fluid flow. APMIS 2001; 109: 241-262.
46. Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL et al. Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem 2002; 277: 3487-3497.
47. Perillo NL, Marcus ME, Baum LG. Galectins: a versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998; 76: 406-412.
48. Sanford GL, Harris-Hooker S. Stimulation of vascular cell proliferation by beta-galactoside specific lectins. FASEB J 1990; 4: 2912-2918.
49. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature 1995; 378: 736-739.
50. Inohara H, Raz A. Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res 1995; 55: 3267-3271.
51. Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 1996; 93: 6737-6742.
52. Konstantinov KN, Robbins BA, Liu FT. Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. Am J Pathol 1996; 148: 25-30.